(SXI) Standex International - Overview
Sector: Industrials | Industry: Specialty Industrial Machinery | Exchange: NYSE (USA) | Market Cap: 3.123m USD | Total Return: 105% in 12m
Sensors, Engraving, Equipment, Components,
Total Rating 61
Safety 81
Buy Signal 1.23
Specialty Industrial Machinery
Industry Rotation: +0.7
Industry Rotation: +0.7
Market Cap:
3.12B
Avg Turnover: 45.5M USD
Avg Turnover: 45.5M USD
ATR:
3.79%
Peers RS (IBD): 81.8
Peers RS (IBD): 81.8
Risk 5d forecast
Volatility35.8%
Rel. Tail Risk-4.55%
Reward TTM
Sharpe Ratio1.91
Alpha53.28
Character TTM
Beta1.255
Beta Downside1.831
Drawdowns 3y
Max DD38.01%
CAGR/Max DD0.85
EPS (Earnings per Share)
EPS CAGR: -45.55%
EPS Trend: -20.9%
EPS Trend: -20.9%
Last SUE: -4.00
Qual. Beats: 0
Qual. Beats: 0
Revenue
Rev. CAGR: 4.26%
Rev. Trend: 61.4%
Rev. Trend: 61.4%
Last SUE: 0.29
Qual. Beats: 0
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Squeeze
Description: SXI Standex International
Standex International Corporation operates in commercial and industrial markets. The company diversifies its operations across five segments: Electronics, Engineering Technologies, Scientific, Engraving, and Specialty Solutions.
The Electronics segment manufactures various sensors and transformers, components used in the broader electrical equipment industry. The Scientific segment provides temperature-controlled equipment for medical and biotech industries, a specialized area within scientific instruments. The Engineering Technologies segment offers customized solutions for aerospace and defense, which are critical sectors for precision manufacturing. The Engraving segment specializes in mold texturizing and roll engraving, serving industrial design needs. The Specialty Solutions segment provides refrigerated and heated display cases and hydraulic cylinders, products common in retail and heavy equipment industries.
For more detailed financial analysis and performance metrics, ValueRay offers in-depth research tools.
- Industrial and commercial market demand drives revenue
- Global manufacturing output impacts segment performance
- Raw material and component costs influence profitability
- Currency fluctuations affect international sales and earnings
- Regulatory compliance costs impact operational expenses
Piotroski VR‑10 (Strict)
6.5
| Net Income: 53.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.33 > 1.0 |
| NWC/Revenue: 36.83% < 20% (prev 45.53%; Δ -8.69% < -1%) |
| CFO/TA 0.05 > 3% & CFO 80.3m > Net Income 53.9m |
| Net Debt (526.5m) to EBITDA (156.3m): 3.37 < 3 |
| Current Ratio: 2.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (12.1m) vs 12m ago 0.25% < -2% |
| Gross Margin: 39.99% > 18% (prev 0.39%; Δ 3.96k% > 0.5%) |
| Asset Turnover: 57.19% > 50% (prev 48.40%; Δ 8.79% > 0%) |
| Interest Coverage Ratio: 3.68 > 6 (EBITDA TTM 156.3m / Interest Expense TTM 34.2m) |
Altman Z''
5.57
| A: 0.21 (Total Current Assets 490.7m - Total Current Liabilities 170.8m) / Total Assets 1.55b |
| B: 0.73 (Retained Earnings 1.14b / Total Assets 1.55b) |
| C: 0.08 (EBIT TTM 126.0m / Avg Total Assets 1.52b) |
| D: 1.22 (Book Value of Equity 990.1m / Total Liabilities 809.8m) |
| Altman-Z'' Score: 5.57 = AAA |
Beneish M
-3.18
| DSRI: 0.70 (Receivables 176.6m/208.8m, Revenue 868.6m/717.7m) |
| GMI: 0.97 (GM 39.99% / 38.91%) |
| AQI: 0.97 (AQ_t 0.55 / AQ_t-1 0.57) |
| SGI: 1.21 (Revenue 868.6m / 717.7m) |
| TATA: -0.02 (NI 53.9m - CFO 80.3m) / TA 1.55b) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of SXI shares?
As of April 09, 2026, the stock is trading at USD 272.83 with a total of 206,019 shares traded.
Over the past week, the price has changed by +4.90%, over one month by +4.76%, over three months by +14.27% and over the past year by +105.01%.
Over the past week, the price has changed by +4.90%, over one month by +4.76%, over three months by +14.27% and over the past year by +105.01%.
Is SXI a buy, sell or hold?
Standex International has received a consensus analysts rating of 4.40.
Therefore, it is recommended to buy SXI.
- StrongBuy: 2
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SXI price?
| Analysts Target Price | 276.8 | 1.5% |
Standex International (SXI) - Fundamental Data Overview
as of 06 April 2026
P/E Trailing = 57.7803 P/E Forward = 25.641
P/S = 3.5955
P/B = 4.4599
P/EG = 0.9516
Revenue TTM = 868.6m USD
EBIT TTM = 126.0m USD
EBITDA TTM = 156.3m USD
Long Term Debt = 534.7m USD (from longTermDebt, last quarter)
Short Term Debt = 12.7m USD (from shortTermDebt, last quarter)
Debt = 623.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 526.5m USD (from netDebt column, last quarter)
Enterprise Value = 3.65b USD (3.12b + Debt 623.5m - CCE 97.0m)
Interest Coverage Ratio = 3.68 (Ebit TTM 126.0m / Interest Expense TTM 34.2m)
EV/FCF = 70.75x (Enterprise Value 3.65b / FCF TTM 51.6m)
FCF Yield = 1.41% (FCF TTM 51.6m / Enterprise Value 3.65b)
FCF Margin = 5.94% (FCF TTM 51.6m / Revenue TTM 868.6m)
Net Margin = 6.20% (Net Income TTM 53.9m / Revenue TTM 868.6m)
Gross Margin = 39.99% ((Revenue TTM 868.6m - Cost of Revenue TTM 521.3m) / Revenue TTM)
Gross Margin QoQ = 39.67% (prev 41.59%)
Tobins Q-Ratio = 2.35 (Enterprise Value 3.65b / Total Assets 1.55b)
Interest Expense / Debt = 1.27% (Interest Expense 7.91m / Debt 623.5m)
Taxrate = 24.06% (6.54m / 27.2m)
NOPAT = 95.7m (EBIT 126.0m * (1 - 24.06%))
Current Ratio = 2.87 (Total Current Assets 490.7m / Total Current Liabilities 170.8m)
Debt / Equity = 0.89 (Debt 623.5m / totalStockholderEquity, last quarter 700.2m)
Debt / EBITDA = 3.37 (Net Debt 526.5m / EBITDA 156.3m)
Debt / FCF = 10.21 (Net Debt 526.5m / FCF TTM 51.6m)
Total Stockholder Equity = 701.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.55% (Net Income 53.9m / Total Assets 1.55b)
RoE = 7.68% (Net Income TTM 53.9m / Total Stockholder Equity 701.6m)
RoCE = 10.19% (EBIT 126.0m / Capital Employed (Equity 701.6m + L.T.Debt 534.7m))
RoIC = 7.63% (NOPAT 95.7m / Invested Capital 1.25b)
WACC = 8.83% (E(3.12b)/V(3.75b) * Re(10.40%) + D(623.5m)/V(3.75b) * Rd(1.27%) * (1-Tc(0.24)))
Discount Rate = 10.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.83%
[DCF] Terminal Value 74.16% ; FCFF base≈52.6m ; Y1≈48.7m ; Y5≈44.2m
[DCF] Fair Price = 13.51 (EV 690.2m - Net Debt 526.5m = Equity 163.7m / Shares 12.1m; r=8.83% [WACC]; 5y FCF grow -9.42% → 3.0% )
EPS Correlation: -20.89 | EPS CAGR: -45.55% | SUE: -4.0 | # QB: 0
Revenue Correlation: 61.41 | Revenue CAGR: 4.26% | SUE: 0.29 | # QB: 0
EPS current Year (2026-06-30): EPS=8.88 | Chg7d=-0.117 | Chg30d=+0.019 | Revisions Net=-2 | Growth EPS=+11.3% | Growth Revenue=+13.4%
EPS next Year (2027-06-30): EPS=10.46 | Chg7d=-0.232 | Chg30d=+0.087 | Revisions Net=-2 | Growth EPS=+17.8% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 8.7% (Discount Rate 10.4% - Earnings Yield 1.7%)
[Growth] Growth Spread = -3.2% (Analyst 5.4% - Implied 8.7%)
External Resources